TSW
TDOC icon

Thompson Siegel & Walmsley’s Teladoc Health TDOC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed -$1K – 675
2020
Q2 		$1K Buy
+5
New +$876 ﹤0.01% 652

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Thompson Siegel & Walmsley's TDOC Position: Q3 2020 in Review

Thompson Siegel & Walmsley sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 5 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in TDOC in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Thompson Siegel & Walmsley reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 5 Teladoc Health shares in Q3 2020, an estimated $1K.
  • Thompson Siegel & Walmsley first reported a position in Teladoc Health in Q2 2020 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Teladoc Health position peaked at $1K in Q2 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2020, filed 12 Nov 2020.